Page last updated: 2024-08-22

angiotensin ii and Degenerative Diseases, Central Nervous System

angiotensin ii has been researched along with Degenerative Diseases, Central Nervous System in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (85.71)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Diaz-Ruiz, C; Dominguez-Meijide, A; Garrido-Gil, P; Guerra, MJ; Labandeira-Garcia, JL; Villar-Cheda, B1
Lin, X; Lu, J; Shi, J; Tian, M; Wu, L; Zhang, Y1
Re, RN1
Beiroa, D; Diaz-Ruiz, C; Labandeira-Garcia, JL; Rodriguez-Pallares, J; Rodriguez-Perez, AI1
Borrajo, A; Diaz-Ruiz, C; Garrido-Gil, P; Labandeira-Garcia, JL; Rodriguez-Perez, AI1
Dikalov, S1
Saavedra, JM1

Reviews

3 review(s) available for angiotensin ii and Degenerative Diseases, Central Nervous System

ArticleYear
A possible mechanism for the progression of chronic renal disease and congestive heart failure.
    Journal of the American Society of Hypertension : JASH, 2015, Volume: 9, Issue:1

    Topics: Angiotensin II; Disease Progression; Heart Failure; Humans; Neurodegenerative Diseases; Renal Insufficiency, Chronic; Renin-Angiotensin System; Up-Regulation

2015
Cross talk between mitochondria and NADPH oxidases.
    Free radical biology & medicine, 2011, Oct-01, Volume: 51, Issue:7

    Topics: Aging; Angiotensin II; Animals; Antioxidants; Atherosclerosis; Diabetes Mellitus; Humans; Hypertension; Mice; Mitochondria; NADPH Oxidases; Neurodegenerative Diseases; Nitric Oxide Synthase Type III; Organophosphorus Compounds; Oxidation-Reduction; Oxidative Stress; Piperidines; Rabbits; Rats; Reactive Oxygen Species; Signal Transduction; Superoxide Dismutase; Xanthine Oxidase

2011
Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.
    Clinical science (London, England : 1979), 2012, Volume: 123, Issue:10

    Topics: Aging; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Biomarkers; Brain; Brain Diseases; Brain Injuries; Brain Ischemia; Humans; Inflammation; Mood Disorders; Neurodegenerative Diseases; Neuroprotective Agents; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Risk Factors; Stress, Physiological; Stroke

2012

Other Studies

4 other study(ies) available for angiotensin ii and Degenerative Diseases, Central Nervous System

ArticleYear
Aging-Related Overactivity of the Angiotensin/AT1 Axis Decreases Sirtuin 3 Levels in the Substantia Nigra, Which Induces Vulnerability to Oxidative Stress and Neurodegeneration.
    The journals of gerontology. Series A, Biological sciences and medical sciences, 2020, 02-14, Volume: 75, Issue:3

    Topics: Age Factors; Angiotensin II; Animals; Male; Mice; Neurodegenerative Diseases; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Sirtuin 3; Substantia Nigra

2020
Angiotensin II triggers autophagy and apoptosis in PC12 cell line: An in vitro Alzheimer's disease model.
    Brain research, 2019, 09-01, Volume: 1718

    Topics: Alzheimer Disease; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Autophagy; Imidazoles; Losartan; Models, Biological; Neurodegenerative Diseases; PC12 Cells; Pyridines; Rats; Receptor, Angiotensin, Type 1

2019
Reciprocal regulation between sirtuin-1 and angiotensin-II in the substantia nigra: implications for aging and neurodegeneration.
    Oncotarget, 2015, Sep-29, Volume: 6, Issue:29

    Topics: Aging; Angiotensin II; Animals; Brain; Cell Line; Dopaminergic Neurons; Gene Expression Regulation; Homozygote; Humans; Immunohistochemistry; Inflammation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Microscopy, Fluorescence; NADPH Oxidases; Neurodegenerative Diseases; Neuroglia; Neurons; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Resveratrol; Sirtuin 1; Stilbenes; Substantia Nigra

2015
Crosstalk between insulin-like growth factor-1 and angiotensin-II in dopaminergic neurons and glial cells: role in neuroinflammation and aging.
    Oncotarget, 2016, May-24, Volume: 7, Issue:21

    Topics: 1-Methyl-4-phenylpyridinium; Age Factors; Aging; Angiotensin II; Animals; Apoptosis; Cells, Cultured; Dopaminergic Neurons; Fluorescent Antibody Technique; Humans; Immunohistochemistry; Inflammation; Injections, Intraventricular; Insulin-Like Growth Factor I; Microglia; Neurodegenerative Diseases; Oxidative Stress; Primary Cell Culture; Rats; Receptor, Angiotensin, Type 1; Receptor, IGF Type 1; Renin-Angiotensin System; Substantia Nigra

2016